713
Participants
Start Date
October 31, 2005
Primary Completion Date
August 31, 2006
Study Completion Date
August 31, 2006
Fixed dose combination telmisartan 80 mg + HCTZ 25 mg
Fixed dose combination telmisartan 80 mg + HCTZ 12.5 mg
Boehringer Ingelheim Investigational Site, Taipei
Boehringer Ingelheim Investigational Site, Taipei
Boehringer Ingelheim Investigational Site, Midrand
Boehringer Ingelheim Investigational Site, Johannesburg
Boehringer Ingelheim Investigational Site, Johannesburg
Boehringer Ingelheim Investigational Site, Lenasia
Boehringer Ingelheim Investigational Site, Lenasia South
Boehringer Ingelheim Investigational Site, Saint-Imier
Boehringer Ingelheim Investigational Site, Birker?d
Boehringer Ingelheim Investigational Site, Basel
Boehringer Ingelheim Investigational Site, Basel
Boehringer Ingelheim Investigational Site, Basel
Boehringer Ingelheim Investigational Site, Durban
Boehringer Ingelheim Investigational Site, Bellinzona
Boehringer Ingelheim Investigational Site, Vezia
Boehringer Ingelheim Investigational Site, Bellville
Hospital Gral. Jerez de la Frontera, Jerez de La Frontera / Cadiz
Hospital del Conxo, Santiago de Compostela
Ospedale Arnaboldi, Broni (PV)
Hospital Universitario Gregorio Mara?on, Madrid
Hospital General de Mostoles - Medicina Interna, Mostoles / Madrid
Ospedale Civile, Vittorio Veneto (TV)
Azienda Ospedaliera Universita di Ferrara, Ferrara
Hospital de Galdakao, Galdakao / Vizcaya
ALTI, Angers
ALTI, Angers
Boehringer Ingelheim Investigational Site, Ingelheim
Boehringer Ingelheim Investigational Site, Frankfurt am Main
Boehringer Ingelheim Investigational Site, Rodgau-Dudenhofen
Boehringer Ingelheim Investigational Site, Flörsheim
Boehringer Ingelheim Investigational Site, Unterschneidheim
Mg Recherches, Paris
Boehringer Ingelheim Investigational Site, Haag
Boehringer Ingelheim Investigational Site, Nuremberg
Hopital Avicenne, Bobigny
Boehringer Ingelheim Investigational Site, Kuching, Sarawak
Boehringer Ingelheim Investigational Site, Seoul
Boehringer Ingelheim Investigational Site, Seoul
Boehringer Ingelheim Investigational Site, Incheon
Boehringer Ingelheim Investigational Site, Haderslev
Boehringer Ingelheim Investigational Site, Odder
Boehringer Ingelheim Investigational Site, R?dovre
Boehringer Ingelheim Investigational Site, Vildbjerg
Boehringer Ingelheim Investigational Site, Helsinki
Boehringer Ingelheim Investigational Site, Joensuu
Boehringer Ingelheim Investigational Site, Kokkola
Boehringer Ingelheim Investigational Site, Turku
Boehringer Ingelheim Investigational Site, Turku
Boehringer Ingelheim Investigational Site, Ellefeld
Boehringer Ingelheim Investigational Site, Hong Kong
Boehringer Ingelheim Investigational Site, Birr
Boehringer Ingelheim Investigational Site, Carrigallen
Boehringer Ingelheim Investigational Site, Dublin
Boehringer Ingelheim Investigational Site, Enniscorthy
Boehringer Ingelheim Investigational Site, Gorey
Boehringer Ingelheim Investigational Site, Mallow
Boehringer Ingelheim Investigational Site, New Ross
Boehringer Ingelheim Investigational Site, Toomyvara
Boehringer Ingelheim Investigational Site, Taipei
IRCCS San Raffaele, Roma
Boehringer Ingelheim Investigational Site, Bennebroek
Boehringer Ingelheim Investigational Site, Ewijk
Boehringer Ingelheim Investigational Site, Helmond
Boehringer Ingelheim Investigational Site, Hoogwoud
Boehringer Ingelheim Investigational Site, Nijverdal
Boehringer Ingelheim Investigational Site, Oude Pekela
Boehringer Ingelheim Investigational Site, Oude Pekela
Boehringer Ingelheim Investigational Site, Rijswijk
Boehringer Ingelheim Investigational Site, Roelofarendsveen
Boehringer Ingelheim Investigational Site, Rotterdam
Boehringer Ingelheim Investigational Site, Elverum
Boehringer Ingelheim Investigational Site, Moelv
Boehringer Ingelheim Investigational Site, Oslo
Boehringer Ingelheim Investigational Site, Skedsmokorset
Boehringer Ingelheim Investigational Site, Tolvsr?d
Boehringer Ingelheim Investigational Site, Pretoria
Hospital Municipal de Badalona, Badalona / Barcelona
C.A.P. Mosen Cinto Verdaguer, L'Hospitalet de Llobregat / Barcelona
C.A.P. Ronda Cerdanya, Mataro (Barcelona)
Boehringer Ingelheim Investigational Site, Eksjö
Boehringer Ingelheim Investigational Site, Karlstad
Boehringer Ingelheim Investigational Site, Karlstad
Boehringer Ingelheim Investigational Site, Uddevalla
Boehringer Ingelheim Investigational Site, Uppsala
Lead Sponsor
Boehringer Ingelheim
INDUSTRY